-
October 23, 2026
A Texas federal judge has denied Strive Specialties Inc.'s bid to undo her judgment dismissing the compounding pharmacy's lawsuit that accuses Eli Lilly and Novo Nordisk of blocking competition for GLP-1 medications, saying Strive's claim that the court committed a manifest legal error was based on the company's own misunderstanding.
-
October 23, 2026
Vape maker Savage Enterprises, two distributors and a California testing lab must not be allowed to shake a lawsuit accusing them of trying to pass off vape pens with illegal levels of THC as legal hemp products, consumers told an Arkansas federal court, saying their dismissal bids are moot because there is a new complaint.
-
October 23, 2026
An Ohio state jury on Friday found in Johnson & Johnson's favor in a wrongful death suit brought by the family of a woman who alleged that her mesothelioma was caused by her longtime use of talc cosmetic products containing asbestos.
-
October 23, 2026
IQVIA Holdings Inc. should have brought its poaching suit against four former employees accused of defecting to a competitor in Delaware court under a forum selection clause in their employment contracts, a North Carolina Business Court judge ruled Thursday in dismissing the case.
-
October 23, 2026
Vanda Pharmaceuticals and Alembic Pharmaceuticals notified a Delaware federal judge Friday that they have settled a patent dispute over Alembic's planned generic version of Vanda's schizophrenia drug Fanapt.
-
October 23, 2026
A group of Baxter International shareholders should not be allowed to pursue securities fraud claims over a new fluid pump product later deemed defective simply because the product and its revenues performed worse than publicly expected, the company and its executives have told an Illinois federal judge.
-
October 23, 2026
A Pennsylvania federal judge refused Friday to extend a pause on the generic-drug price-fixing multidistrict litigation, eyeing setting a new trial date for the first bellwether case initially paused by a conflict with a special master that the drugmakers say now covers "the entire MDL."
-
October 23, 2026
The Federal Circuit has denied insulin product developer Insulet Corp.'s request to keep an injunction in place against rival EOFlow Co. Ltd. while it appeals an axed $59 million trade secrets jury verdict to the U.S. Supreme Court.
-
October 23, 2026
Artificial intelligence-powered cardiac imaging company Heartflow Inc. is accusing a competitor of infringing its patents covering a noninvasive heart test and luring almost a dozen of its employees to make a similar product.
-
October 23, 2026
Early-stage biotechnology firm Lycia Therapeutics began trading Friday after raising $318 million in its upsized initial public offering steered by Fenwick & West LLP and Cooley LLP.
-
October 23, 2026
Smart ring-maker Ouraring Inc. has filed another lawsuit against rival Ultrahuman Healthcare Inc., asserting two patents it said were not addressed in an earlier suit that resulted in an import ban that was later lifted when Ultrahuman redesigned its product.
-
October 23, 2026
In this week's Taxation With Representation, EQT Private Equity announces a takeover offer for life sciences testing company Qiagen NV, Salesforce acquires customer engagement platform Braze and London Stock Exchange Group buys U.S. credit intelligence provider Octus.
-
October 23, 2026
The U.S. Department of Commerce is opening investigations into whether certain chemical compounds imported from China are being sold at less than fair value and are subsidized, the department said Friday.
-
October 22, 2026
Nestle was hit with a proposed false advertising class action Wednesday in New Jersey federal court alleging its Solgar VM-75 supplements contain dangerous levels of vitamin B6, which can heighten the risk of developing peripheral neuropathy or worsen the condition.
-
October 22, 2026
The coalition fighting marijuana legalization won a partial victory after a Drug Enforcement Administration's administrative law judge on Thursday allowed into the record a U.S. Government Accountability Office report the group championed but denied new testimony on it, saying the report "speaks for itself."
-
October 22, 2026
The Texas Office of the Attorney General on Thursday announced that pharmaceutical company Gilead Sciences Inc. signed off on a $45 million settlement to end claims that the company ran an illegal kickback scheme in order to get prescribers to favor its medications.
-
October 22, 2026
An indoor air quality company failed to prove academic publisher Elsevier acted with malice in printing an article questioning the effectiveness of its air purification technology sufficient to sustain a claim for defamation, a North Carolina federal judge ruled Thursday.
-
October 22, 2026
The full Ninth Circuit declined to reconsider an appellate panel's recent decision reviving a surgical repair company's antitrust suit alleging Intuitive Surgical blocked third parties from supplying parts for its popular da Vinci surgery robot, according to an order issued Thursday.
-
October 22, 2026
Johnson & Johnson told the Third Circuit Thursday that the U.S. Supreme Court's recent decision not to take up a group of executives' federal benefits dispute backed its position in an appeal from J&J workers who alleged their health plans were saddled with excessive prescription drug fees.
-
October 22, 2026
Mylan Pharmaceuticals has struck another deal to resolve claims that it illegally inflated prices for EpiPens, this time settling Connecticut state enforcers' allegations of antitrust and consumer protection law violations for $8 million.
-
October 22, 2026
The Purdue Pharma bankruptcy trust and trustees for some members of the Sackler family have filed separate documents in a New York bankruptcy court challenging moves they described as continued attempts by Richard S. Sackler and his wife, Lin Gao, to block parts of the drugmaker's bankruptcy plan.
-
October 22, 2026
10x Genomics has told a Delaware federal judge it will no longer pursue a patent case against Parse Biosciences Inc. over methods of analyzing genetic information, a move following the Federal Circuit's refusal to revive the remaining three patents-at-issue.
-
October 22, 2026
The Federal Trade Commission has requested additional information about Curium's planned $8 billion acquisition of fellow radiopharmaceutical company Lantheus Holdings Inc., extending a waiting period that prevents the transaction from closing.
-
October 22, 2026
The Patent Trial and Appeal Board has invalidated claims in an Inari Medical Inc. patent on valves used in surgery to prevent blood loss, handing another win to challenger Imperative Care as it fends off an infringement lawsuit in California.
-
October 22, 2026
DLA Piper has hired a former Shook Hardy & Bacon LLP product liability partner in San Francisco who has decades of experience defending companies in high-stakes disputes involving hundreds of millions of dollars.